Metformin, a type 2 diabetes medication, has shown potential in breast cancer prevention and treatment. Studies suggest that it inhibits cancer cell growth, reduces inflammation, and improves insulin sensitivity. Clinical trials are ongoing to evaluate metformin’s efficacy in preventing breast cancer and reducing recurrence. The link between diabetes and breast cancer highlights the role of metabolic pathways in cancer development, and further research is needed to explore the potential of drugs like metformin in breast cancer management.
